Near-Infrared Light (tPBM) Therapy for ADHD: From Research to Application — A New Hope for Non-Invasive Treatment

Near-Infrared Light (tPBM) Therapy for ADHD: From Research to Application — A New Hope for Non-Invasive Treatment

Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental condition. For many years, medication has been the primary treatment approach. However, some individuals experience limited effectiveness or difficulty tolerating side effects.

With rapid advancements in the field of neuromodulation, near-infrared light therapy (NIR)—specifically transcranial photobiomodulation (tPBM)—has emerged as a promising new option for ADHD support. Thanks to its non-invasive nature, safety profile, and lack of medication dependency, tPBM is gaining attention as a potential alternative approach, offering new hope for many individuals and families.

1. What Is Transcranial Photobiomodulation (tPBM)?

Transcranial photobiomodulation (tPBM) is a neuromodulation technique based on near-infrared light (NIR). It works by delivering specific wavelengths of near-infrared light through the skull to targeted areas of the brain, allowing non-invasive interaction with neural tissue.

This process may influence cellular metabolism, brain network activity, and cognitive function at a deeper level without the use of drugs, invasive procedures, or strong external stimulation. As a result, it is considered a natural and non-invasive approach.

Currently, this technology has shown promising results in research related to conditions such as depression and anxiety. As scientific studies continue to expand, its potential role in supporting individuals with ADHD is receiving increasing attention from the research community.

2. Why Near-Infrared Light Shows Promise for ADHD: Four Key Scientific Mechanisms

1. Clinical Research Is Advancing, and Early Potential Has Been Demonstrated

After showing encouraging results in research related to neurological and mental health conditions such as depression and anxiety, near-infrared light therapy is now being explored in clinical studies for ADHD, autism, schizophrenia, bipolar disorder, and other related conditions.

• Several dedicated studies investigating tPBM for ADHD have been registered on authoritative platforms such as ClinicalTrials.gov.
• Leading organizations in brain photobiomodulation research, including companies like Vielight, have also identified ADHD as an important focus for clinical collaboration and scientific investigation.

As more research and clinical data emerge, near-infrared light therapy is increasingly being recognized as a promising non-pharmacological approach worth exploring for ADHD support.

2. Targeted Activation of the Prefrontal Cortex to Support Core Cognitive Functions

One of the key neurological characteristics associated with ADHD is reduced activity in the prefrontal cortex (PFC). This area of the brain plays a critical role in attention regulation, executive function, working memory, and impulse control. When PFC activity is lower than typical levels, individuals may experience difficulties such as distractibility, weaker executive functioning, reduced working memory capacity, and slower response control.

Research suggests that specific wavelengths of near-infrared light—such as 810 nm and 1064 nm—can interact with regions of the prefrontal cortex, including the right prefrontal area. Studies exploring this interaction have reported potential improvements in areas such as:

• Sustained attention
• Working memory performance
• Response speed and accuracy
• Higher-level rule execution and cognitive control

These cognitive domains are closely related to the primary challenges experienced by many individuals with ADHD.

3. Supporting Healthier Brain Network Balance: Shifting from “Mind-Wandering” to “Focus”

Another key factor associated with ADHD involves the balance between two important brain networks: the Default Mode Network (DMN) and the Central Executive Network (CEN).

In simple terms:

• The DMN is more active during rest, daydreaming, and internal thought processes.
• The CEN is responsible for focus, problem-solving, and goal-directed thinking.

In many individuals with ADHD, research suggests that the DMN may remain overly active when the brain should be engaging the CEN. This imbalance can make it more difficult to shift from a passive, distracted state into a focused and task-oriented one.

Research observations using technologies such as magnetoencephalography (MEG) and electroencephalography (EEG) suggest that tPBM may help:

• Support the brain’s shift from DMN-dominant activity to CEN-dominant activity
• Enhance directed information flow and functional connectivity in the brain
• Promote a more balanced interaction between major brain networks

These effects may contribute to improvements in attention regulation, reduced mind-wandering, and stronger cognitive control.

4. Supporting Brain Energy Metabolism

Some research suggests that certain ADHD-related symptoms may be associated with reduced blood flow or lower metabolic activity in specific brain regions.

Near-infrared light has been shown to interact with mitochondria within neurons, particularly by influencing an enzyme called cytochrome c oxidase (CCO). This interaction may support several biological processes, including:

• Increased production of ATP, the primary energy source for cells
• Release of nitric oxide (NO), which can help relax and widen blood vessels
• Improved cerebral blood flow (CBF) and oxygen availability in targeted brain regions

These processes may help support healthier brain metabolism, which plays an important role in maintaining attention and managing cognitively demanding tasks.

3. Key Advantages of Near-Infrared Light (tPBM): Non-Drug, Non-Invasive, and Suitable for Home Use

For individuals who do not respond well to traditional ADHD interventions—or who experience difficulty tolerating medication side effects such as sleep disturbances, reduced appetite, mood fluctuations, or dependency concerns—near-infrared light therapy may offer a complementary approach worth exploring.

Potential advantages include:

✅ Non-invasive physical intervention — no surgery or medication required
✅ No drug-related side effects associated with pharmaceutical treatments
✅ Convenient for regular home use, making it easier to maintain consistent routines
✅ Focus on underlying brain processes, rather than temporarily suppressing symptoms

4. Future Outlook: A New Direction for ADHD Support

Although near-infrared photobiomodulation (tPBM) has not yet become a standardized treatment for ADHD, ongoing research and clinical trials continue to explore its potential.

Based on published studies and current scientific investigations, researchers and clinicians are increasingly interested in the role that near-infrared light therapy may play in the future—as a non-pharmacological approach for supporting cognitive function and mental well-being.

As research progresses, tPBM may become an important complementary option in the broader landscape of ADHD management and cognitive enhancement.

As more randomized controlled trials are completed and the body of scientific evidence continues to grow, this gentle, safe, and promising form of physical neuromodulation may offer a new and reliable pathway for individuals seeking support with attention-related challenges.

If you're interested in exploring tPBM, feel free to contact us to learn more.